HMOX1 and metabolic dysfunction-associated steatotic liver disease: The results of our study have led to the identification of six compounds that induce HMOX1 expression and exhibit protective effects against oxidative stress and steatosis in vitro, highlighting their potential as therapeutic agents for NAFLD.